Cough-Generated Aerosols of NTM in Cystic Fibrosis
Cough-Generated Aerosols of Nontuberculous Mycobacteria in Patients With Cystic Fibrosis
1 other identifier
observational
5
1 country
1
Brief Summary
Non-tuberculous mycobacteria (NTM) are opportunistic pathogens normally found in soil and water that are being cultured from Cystic Fibrosis (CF) airways at an increasing frequency. They have been demonstrated to cause clinically significant lung disease in some cases and the transmission of NTM, from person to person has been proposed. There are currently no standardized guidelines for isolation of those colonized or infected with NTM. The investigators will measure particle droplet size from patients with CF who have positive sputum cultures for NTM with the hypothesis that they will be in a range that can spread infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2013
CompletedFirst Posted
Study publicly available on registry
March 21, 2013
CompletedStudy Start
First participant enrolled
April 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedOctober 14, 2015
October 1, 2015
2.2 years
March 19, 2013
October 13, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The number of CF patients who produce culturable aerosols of NTM during coughing.
Patients with CF and a positive sputum or bronchoalveolar lavage (BAL) culture for NTM will cough into a chamber filled with culture plates that can measure droplet size. The investigators are looking for large droplets, that could land on surfaces and be a source for infection transmission, as well as fine droplets(5 microns or less)that are consistent with airborne transmission.
6 weeks
Study Arms (1)
CF with culturable NTM
CF patients who produce culturable aerosols of NTM will receive the following test: pulmonary function test, collecting a sputum culture if possible, coughing for 5 minutes into a tube connected to a canister, hypertonic saline and albuterol will be given after the 5 minutes of coughing and then they would repeat with another 5 minutes of coughing. There can be a break inbetween the coughing if needed.
Interventions
CF patients who produce culturable aerosols of NTM will receive the following test: pulmonary function test, collecting a sputum culture if possible, coughing for 5 minutes into a tube connected to a canister, hypertonic saline and albuterol will be given after the 5 minutes of coughing and then they would repeat with another 5 minutes of coughing. There can be a break inbetween the coughing if needed.
Eligibility Criteria
Specialialty Clinics, Pulmonary
You may qualify if:
- Age greater than or equal to age 8 years
- Confirmed Diagnosis of CF
- Sputum/Throat/Bronchoscopic culture positive for NTM within the last 12 months
You may not qualify if:
- Pregnancy
- Pneumothorax within the last 6 months
- Forced Expiratory Volume at one second \<30% predicted
- Hemoptysis greater than 1 tablespoon within the last 7 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Floridalead
- Children's Miracle Networkcollaborator
- UF Pedscollaborator
Study Sites (1)
University of Florida Clinical Research Center
Gainesville, Florida, 32610, United States
Biospecimen
Sputum cultures
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pamela M Schuler, MD
University of Florida
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 19, 2013
First Posted
March 21, 2013
Study Start
April 1, 2013
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
October 14, 2015
Record last verified: 2015-10